CUSTOPHARM INC.
CARLSBAD, TX

Custopharm Inc. is a dynamic pharmaceutical entity focused on the development and commercialization of sterile injectable products. Founded in Carlsbad, Florida, with a mailing address at 2325 Camino Vida Roble, it operates as an agent company, having been incorporated on May 27, 2016. Led by experienced executives such as William (Bill) for Business Development and Licensing, Mohammad for Manufacturing Strategy, and Michael Davidson in similar strategic roles, Custopharm is committed to expanding its pharmaceutical portfolio through strategic acquisitions and partnerships with both development and manufacturing companies. William brings over two decades of leadership experience from renowned firms like Novartis and Bedford Laboratories, focusing on generic injectables and peptide innovations. Mohammad's expertise lies in process development for diverse dosage forms including biologics, with roles spanning at major pharmaceutical corporations such as Bayer and Baxter. Michael Davidson’s extensive background includes strategic sourcing and operations management across the global pharmaceutical industry. Elaine heads quality assurance and regulatory compliance, maintaining robust partnerships to ensure product safety and efficacy, backed by her 16-year tenure in contract manufacturing organizations like Ajinomoto Althea and Cardinal Health. Custopharm continues to expand its workforce with open positions ranging from analytical scientists to regulatory associates. Located primarily in Palm Beach County, Florida, it holds a registered filing number Q16000000044 under the status of WITHDRAWAL as recorded on October 12, 2022. Despite this, Custopharm proactively pursues new business opportunities and strategic collaborations to enhance its offerings, as detailed on their website, custopharm.com.